Weight-loss, diabetes drugs linked to vision problems in small study

Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study at the University of British Columbia. Some common GLP-1 drugs include Ozempic and Wegovy, which contain semaglutide … Read more

Vision loss risks in patients using popular GLP-1 medications raise concerns

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established. That is the conclusion of a retrospective study published online on Jan. 30 in JAMA Ophthalmology. The study focused on nine patients who had experienced vision problems while … Read more

Vision loss risks in patients using popular GLP-1 medications raise concerns

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established. That is the conclusion of a retrospective study published online on Jan. 30 in JAMA Ophthalmology. The study focused on nine patients who had experienced vision problems while … Read more

New drug may help restoring vision for people with nerve damage: Study | Health

Researchers at the University of Colorado Anschutz Medical Campus found a promising therapeutic candidate that could aid in the restoration of vision in those suffering from multiple sclerosis (MS) and other neurodegenerative diseases. Also read | Why early detection is crucial for glaucoma? Doctor explains warning signs to watch out for The medicine, LL-341070, improves … Read more